Rock inhibitors
AssigneeAmakem NV
InventorsDirk Leysen, Oliver Defert, Nadzeya Kaval, Petra Blom, Sandro Boland
Life of this patent
Estimating the term…
Loading patent…
AssigneeAmakem NV
InventorsDirk Leysen, Oliver Defert, Nadzeya Kaval, Petra Blom, Sandro Boland
Estimating the term…
The present invention relates to new kinase inhibitors, more specifically ROCK inhibitors, compositions, in particular pharmaceuticals, comprising such inhibitors, and to uses of such inhibitors in the treatment and prophylaxis of disease. In particular, the present invention relates to new ROCK inhibitors, compositions, in particular pharmaceuticals, comprising such inhibitors, and to uses of such inhibitors in the treatment and prophylaxis of disease. In addition, the invention relates to methods of treatment and use of said compounds in the manufacture of a medicament for the application to a number of therapeutic indications including sexual dysfunction, inflammatory diseases, ophthalmic diseases and Respiratory diseases.
A method for the treatment of an eye disease or disorder selected from the group consisting of retinopathy, optic neuropathy, glaucoma, inflammatory eye diseases and degenerative retinal diseases, comprising:
A method for the treatment of an eye disease or disorder selected from the group consisting of retinopathy, optic neuropathy, glaucoma, inflammatory eye diseases and degenerative retinal diseases comprising:
Dependencies are inferred from the claim text.